Catalog Number 1013016-150 |
Device Problems
Entrapment of Device (1212); Mechanical Jam (2983); Activation Failure (3270)
|
Patient Problems
Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 03/09/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
The device was received.Investigation is not yet complete.A follow up report will be submitted with all relevant information.
|
|
Event Description
|
It was reported that the patient presented with lower limb arteriosclerosis obliterans.The procedure was performed to treat an occluded lesion in the middle and upper segment of the right superficial femoral artery.A 6.0x150mm absolute pro ll stent was deployed at the lesion without issues.A second 6.0x150mm absolute pro ll stent was deployed about 50mm; however, the thumbwheel could not be turned.The handle was disassembled, but the stent still could not be fully deployed.The stent was removed via surgery.Another 6.0x150mm absolute pro ll stent was used to successfully treat the lesion.There was no clinically significant delay in the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
Visual analysis was performed on the returned device.The reported activation failure, mechanical jam and entrapment were not confirmed.The stent was deployed from the device and was returned in two pieces.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents.The investigation was unable to determine a cause for the reported deployment difficulties and entrapment.Based on the reported information, may be possible that the anatomical conditions induced the distal shaft sheath damage as noted on the returned unit during the insertion process or during the activation, causing partial deployment and the inability to release the stent from the delivery system.However, this could not be confirmed.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
|
Manufacturer Narrative
|
Updated: the investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that the anatomical conditions induced the distal shaft sheath damage as noted on the returned unit during the insertion process or during the activation, causing partial deployment and the inability to release the stent from the delivery system.Although the difficulties encountered appear to be related to procedural circumstances, on may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.H6: investigation conclusions code removed 4315.
|
|
Event Description
|
On may 11th, 2022, abbott determined that a field safety notice (fsn) was required for the absolute pro ll peripheral self-expanding stent system (psess).Abbott has confirmed reports of mechanical locking, stent deployment and partial stent deployment failures, resulting from unintended excessive force used to deploy the stent.To reduce occurrences of deployment failures and associated outcomes, abbott is notifying all users of the potential causes and risks.
|
|
Search Alerts/Recalls
|
|